Literature DB >> 16776621

Flow-cytometric immunophenotyping of normal and malignant lymphocytes.

Tomasz Szczepański1, Vincent H J van der Velden, Jacques J M van Dongen.   

Abstract

During the past two decades, flow-cytometric immunophenotyping of lymphocytes has evolved from a research technique into a routine laboratory diagnostic test. Extensive studies in healthy individuals resulted in detailed age-related reference values for different lymphocyte subpopulations in peripheral blood. This is an important tool for the diagnosis of hematological and immunological disorders. Similar, albeit less detailed, information is now available for other lymphoid organs, e.g., normal bone marrow, lymph nodes, tonsils, thymus and spleen. Flow-cytometric immunophenotyping forms the basis of modern classification of acute and chronic leukemias and is increasingly applied for initial diagnostic work-up of non-Hodgkin's lymphomas. Finally, with multiparameter flow cytometry, it is now possible to identify routinely and reliably low numbers of leukemia and lymphoma cells (minimal residual disease).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16776621     DOI: 10.1515/CCLM.2006.146

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  Evaluation of the Cytotoxic, Anti-Inflammatory, and Immunomodulatory Effects of Withaferin A (WA) against Lipopolysaccharide (LPS)-Induced Inflammation in Immune Cells Derived from BALB/c Mice.

Authors:  Abdullah M Alnuqaydan; Abdulmajeed Almutary; Gh Rasool Bhat; Tanveer Ahmad Mir; Shadil Ibrahim Wani; Mohd Younis Rather; Shabir Ahmad Mir; Bader Alshehri; Sulaiman Alnasser; Faten M Ali Zainy; Bilal Rah
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

3.  Flow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia.

Authors:  Sabrina Uhrmacher; Felix Erdfelder; Karl-Anton Kreuzer
Journal:  Adv Hematol       Date:  2010-09-20

Review 4.  Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.

Authors:  Fatemeh Salari; Mohammad Shahjahani; Saeid Shahrabi; Najmaldin Saki
Journal:  Med Oncol       Date:  2014-10-07       Impact factor: 3.064

5.  Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.

Authors:  Hui-Fang Li; Wen-Tong Meng; Yong-Qian Jia; Neng-Gang Jiang; Ting-Ting Zeng; Yong-Mei Jin; Qiao-Rong Huang; Xue Li; Hong Xu; Xian-Ming Mo
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

6.  Normative data for flow cytometry immunophenotyping of benign lymph nodes sampled by surgical biopsy.

Authors:  Gregory David Scott; Susan K Atwater; Dita A Gratzinger
Journal:  J Clin Pathol       Date:  2017-09-15       Impact factor: 3.411

Review 7.  Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders.

Authors:  Jana Mihályová; Katarína Hradská; Tomáš Jelínek; Benjamin Motais; Piotr Celichowski; Roman Hájek
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

Review 8.  Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.

Authors:  Jan Kulis; Łukasz Sędek; Łukasz Słota; Bartosz Perkowski; Tomasz Szczepański
Journal:  Genes (Basel)       Date:  2022-07-31       Impact factor: 4.141

9.  EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine.

Authors:  J J M van Dongen; A Orfao
Journal:  Leukemia       Date:  2012-09       Impact factor: 11.528

10.  Single-color multitarget flow cytometry using monoclonal antibodies labeled with different intensities of the same fluorochrome.

Authors:  Joonhong Park; Kyungja Han
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.